Clinical & Translational Oncology
- ISSN:
- 1699-048X
1
h-indeks
5
Iqtiboslar
9
Asarlar
1.00
2-yillik oʻrtacha iqtibos
Ishonch signallari
1 dan 3 signal mavjudMustaqil ijobiy signallar — yagona “predator/qonuniy” hukmi emas, balki yaqinlashuvchi tasvir.
- DOAJMaʼlumot yoʻqdoaj.org
- OAK roʻyxatiMaʼlumot yoʻqOAK
- Yaroqli ISSNMavjudISSN
Bu axborot yorligʻi, rasmiy qaror emas. Signal yoʻqligi jazo emas — masalan, mintaqaviy jurnal DOAJ'da boʻlmasligi mumkin.
Vaqt boʻyicha
Vaqt boʻyicha tahlil
Iqtibos sharhi
Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)
- Nashrlar
- Iqtiboslar
Iqtibos tarixi
Nashr tarixi
h-indeks evolyutsiyasi
Yillar boʻyicha jamlangan h-indeks
Eng koʻp iqtibos qilingan asarlar
- Circulating tumor DNA as a predictive biomarker for colorectal cancer postsurgical recurrence: a systematic review and meta-analysis20252 iqtibos
- Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology20261 iqtibos
- The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials20261 iqtibos
- Prognostic value of postoperative circulating tumor DNA for recurrence-free survival in resected non-small cell lung cancer: a systematic review and meta-analysis20251 iqtibos
- CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy20260 iqtibos
- Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer20260 iqtibos
- Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy20260 iqtibos
- CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy20260 iqtibos
- Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities20260 iqtibos